High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study

Bone Marrow Transplant. 1996 Sep:18 Suppl 1:S24-5.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy*
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Female
  • Germany
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Middle Aged
  • Mitoxantrone / administration & dosage
  • Mitoxantrone / adverse effects
  • Neoplasm Staging
  • Thiotepa / administration & dosage
  • Thiotepa / adverse effects
  • Transplantation, Autologous

Substances

  • Cyclophosphamide
  • Thiotepa
  • Mitoxantrone